Cerevel Therapeutics
CERE
#2363
Rank
โ‚ฌ7.11 B
Marketcap
39,06ย โ‚ฌ
Share price
0.00%
Change (1 day)
109.56%
Change (1 year)

EPS for Cerevel Therapeutics (CERE)

EPS in 2024 (TTM): -2,45ย โ‚ฌ

According to Cerevel Therapeutics's latest financial reports the company's current EPS (TTM) is -2,29ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,02ย โ‚ฌ a decrease over its 2021 EPS that were of -1,43ย โ‚ฌ.

EPS history for Cerevel Therapeutics from 2020 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-2,45ย โ‚ฌ
2022-2,02ย โ‚ฌ40.61%
2021-1,43ย โ‚ฌ36.84%
2020-1,05ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Archer Daniels Midland (ADM)
ADM
1,95ย โ‚ฌ-185.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Campbell's
CPB
1,84ย โ‚ฌ-180.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-3,47ย โ‚ฌ 51.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Dupont De Nemours
DD
-0,16ย โ‚ฌ-93.18%๐Ÿ‡บ๐Ÿ‡ธ USA